Mor Herman-Oron

Title: Mor Herman-Oron: Innovator in Cancer Targeting Nanoparticles

Introduction

Mor Herman-Oron is a notable inventor based in Ramat Efal Ramat Gan, Israel. He has made significant contributions to the field of nanotechnology, particularly in the development of cancer-targeting nanoparticles. His innovative work has the potential to enhance therapeutic strategies in oncology.

Latest Patents

Mor Herman-Oron holds a patent for the "Formation of functionalized cancer targeting nanoparticles by supramolecular co-assembly." This invention provides nanoparticle conjugates that incorporate the self-assembling module diphenylalanine (FF) dipeptide into a bioactive moiety. The conjugate self-assembles to form distinct nanometric structures such as nanospheres. Furthermore, the invention includes nanoparticles formed by supramolecular co-assembly of the conjugates with a diphenylalanine (FF) dipeptide or its analogs, generating bioactive self-assembled nanostructures. He has 1 patent to his name.

Career Highlights

Throughout his career, Mor has worked with prominent organizations, including Ramot at Tel Aviv University Ltd. and Tel Hashomer Medical Research Infrastructure and Services Ltd. His experience in these institutions has allowed him to collaborate with leading experts in the field of medical research and technology.

Collaborations

Mor has collaborated with notable colleagues such as Talia Shekhter Zehavi and Ehud Gazit. These partnerships have contributed to the advancement of his research and the successful development of innovative solutions in cancer treatment.

Conclusion

Mor Herman-Oron is a distinguished inventor whose work in cancer-targeting nanoparticles showcases his commitment to advancing medical technology. His contributions have the potential to significantly impact cancer treatment methodologies.